World's Best Scientists 2026 revealed!
Alfredo Berruti

Alfredo Berruti

Overview

Alfredo Berruti is affiliated with the University of Brescia in Italy and has authored over 200 publications primarily in the field of Medicine. Their research work spans various subfields including Surgery, Endocrinology, Diabetes and Metabolism, Oncology, Cancer Research, and Pulmonary and Respiratory Medicine.

The main topics of Alfredo Berruti's research include:

  • Adrenal and Paraganglionic Tumors
  • Cancer, Hypoxia, and Metabolism
  • Hormonal Regulation and Hypertension
  • Pituitary Gland Disorders and Treatments
  • Glioma Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Neuroblastoma Research and Treatments

Frequent co-authors in their publications are:

  • Deborah Cosentini
  • Salvatore Grisanti
  • Massimo Terzolo
  • Marta Laganà
  • Sandra Sigala

Alfredo Berruti has contributed several papers published in notable venues, including:

  • Annals of Oncology (12 publications)
  • Cancers (8 publications)
  • ESMO Open (7 publications)
  • Endocrine (6 publications)
  • Endocrine Abstracts (5 publications)

Selected recent papers authored or co-authored by Alfredo Berruti include:

  • "Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up," 2020, Annals of Oncology
  • "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up," 2020, Annals of Oncology
  • "Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology," 2020, European Urology Focus
  • "Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study," 2023, The Lancet Diabetes & Endocrinology
  • "Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience," 2020, Cancers

Best Publications

  • Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

    S Filetti;C Durante;D Hartl;D Hartl;S Leboulleux;S Leboulleux

  • Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    Martin Fassnacht;Massimo Terzolo;Bruno Allolio;Eric Baudin

  • Adjuvant mitotane treatment for adrenocortical carcinoma.

    Massimo Terzolo;Alberto Angeli;Martin Fassnacht;Fulvia Daffara

  • Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    Marianne Pavel;Kjell Öberg;Massimo Falconi;Eric Krenning

  • Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

    S. Bovio;A. Cataldi;G. Reimondo;P. Sperone

  • European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

    Martin Fassnacht;Olaf M. Dekkers;Olaf M. Dekkers;Tobias Else;Eric Baudin;Eric Baudin

  • Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy

    Alfredo Berruti;Luigi Dogliotti;Carlo Terrone;Stefania Cerutti

  • Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    A. Berruti;E. Baudin;H. Gelderblom;H. R. Haak

  • Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

    Alfredo Berruti;Massimo Terzolo;Paola Sperone;Anna Pia

  • Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

    Martin Fassnacht;Alfredo Berruti;Eric Baudin;Michael J Demeure

  • Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.

    Daniele Generali;Alfredo Berruti;Maria P Brizzi;Leticia Campo

  • Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    M. Fassnacht;G. Assie;E. Baudin;G. Eisenhofer

  • Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies

    Alfredo Berruti;Vito Amoroso;Fabio Gallo;Valentina Bertaglia

  • Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline.

    Alfredo Berruti;Luigi Dogliotti;Raffaella Bitossi;Giuseppe Fasolis

  • Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer

    Francesco Porpiglia;Cristian Fiori;Fulvia Daffara;Barbara Zaggia

  • Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer Patients

    Alberto Bottini;Daniele Generali;Maria Pia Brizzi;Stephen B. Fox

  • Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study

    R. Libé;I. Borget;C.L. Ronchi;B. Zaggia

  • Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study.

    Ilse G. Hermsen;Martin Fassnacht;Massimo Terzolo;Saskia Houterman

  • Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

    Michele Maio;Karl Lewis;Lev Demidov;Mario Mandalà

  • Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

    Gauthier Bouche;Nicolas André;Shripad Banavali;Frank Berthold

Frequent Co-Authors

Massimo Terzolo
Massimo Terzolo University of Turin
Mauro Papotti
Mauro Papotti University of Turin
Francesco Porpiglia
Francesco Porpiglia University of Turin
Stephen B. Fox
Stephen B. Fox Peter MacCallum Cancer Centre
Martin Fassnacht
Martin Fassnacht University of Würzburg
Vittorio Ferrari
Vittorio Ferrari University of Brescia
Giorgio V. Scagliotti
Giorgio V. Scagliotti University of Turin
Eric Baudin
Eric Baudin Institut Gustave Roussy
adrian l harris
adrian l harris University of Oxford
Daniele Santini
Daniele Santini Università Campus Bio-Medico

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond traditional paths in medicine, there are a variety of online programs that open doors to diverse healthcare careers in the USA. Pursuing a health administration degree online can lead to leadership roles in hospitals, clinics, and healthcare organizations, combining patient care with business management.

For those seeking advanced credentials, online mha programs affordable options make it easier to gain specialized expertise in healthcare administration without the burden of high tuition costs. These programs focus on equipping graduates with strong managerial and analytical skills.

If your interests lean toward advanced clinical practice, research, or education, consider the cheapest dnp programs available online. A Doctor of Nursing Practice (DNP) qualifies nurses for top-tier positions and greater responsibility in patient care and healthcare policy.

Similarly, aspiring pharmacists can explore online pharmd programs that provide flexible learning opportunities and prepare graduates for licensure and clinical roles in pharmacy. These related online pathways make it possible to build a rewarding healthcare career with accessibility and affordability in mind.

Best Scientists Citing Alfredo Berruti

Trending Scientists

Recently Published Articles